These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 26345955)
1. Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance. Yu X; Li Y; Chen SW; Shi Y; Xu F Genet Mol Res; 2015 Aug; 14(3):10185-92. PubMed ID: 26345955 [TBL] [Abstract][Full Text] [Related]
2. Expression of GPC3 protein and its significance in lung squamous cell carcinoma. Lin Q; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M Med Oncol; 2012 Jun; 29(2):663-9. PubMed ID: 21556932 [TBL] [Abstract][Full Text] [Related]
3. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123 [TBL] [Abstract][Full Text] [Related]
4. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma. Aviel-Ronen S; Lau SK; Pintilie M; Lau D; Liu N; Tsao MS; Jothy S Mod Pathol; 2008 Jul; 21(7):817-25. PubMed ID: 18469798 [TBL] [Abstract][Full Text] [Related]
5. [Expression of glypican-3 in lung squamous cell carcinoma and adenocarcinoma and its relation with prognosis]. Li H; Deng Q; Huang L; Tang H; Cheng X Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):212-5. PubMed ID: 23443774 [TBL] [Abstract][Full Text] [Related]
6. Glypican-3 promotes cell proliferation and tumorigenesis through up-regulation of β-catenin expression in lung squamous cell carcinoma. Wang D; Gao Y; Zhang Y; Wang L; Chen G Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160489 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells. Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456 [TBL] [Abstract][Full Text] [Related]
8. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. Zhang L; Liu H; Sun L; Li N; Ding H; Zheng J Acta Histochem; 2012 Oct; 114(6):547-52. PubMed ID: 22119409 [TBL] [Abstract][Full Text] [Related]
9. Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database. Moek KL; Fehrmann RSN; van der Vegt B; de Vries EGE; de Groot DJA Am J Pathol; 2018 Sep; 188(9):1973-1981. PubMed ID: 29935166 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of glypican 3 in thyroid cancer. Yamanaka K; Ito Y; Okuyama N; Noda K; Matsumoto H; Yoshida H; Miyauchi A; Capurro M; Filmus J; Miyoshi E Oncology; 2007; 73(5-6):389-94. PubMed ID: 18511877 [TBL] [Abstract][Full Text] [Related]
11. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells]. Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080 [TBL] [Abstract][Full Text] [Related]
12. Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma. Li K; Pan X; Bi Y; Xu W; Chen C; Gao H; Shi B; Jiang H; Yang S; Jiang L; Li Z Oncotarget; 2016 Jan; 7(3):2496-507. PubMed ID: 26684028 [TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of Claudin-7 and slug expression in lung squamous cell carcinoma and adenocarcinoma]. Li R; Zhang D; Cai C; Dong J Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):492-6. PubMed ID: 21645451 [TBL] [Abstract][Full Text] [Related]
14. The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression. Xue R; Feng J; Meng Q; Lv F; Zhu Y; Yu H; Zhang S; Song C; Sun L; Yue Z; Feng S; Che R; Xiang Q; Jing X J Gastroenterol Hepatol; 2017 Aug; 32(8):1503-1511. PubMed ID: 28087980 [TBL] [Abstract][Full Text] [Related]
16. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma. Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662 [TBL] [Abstract][Full Text] [Related]
17. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. Yao H; Yang Z; Liu Z; Miao X; Yang L; Li D; Zou Q; Yuan Y Cancer Biomark; 2016; 17(4):397-404. PubMed ID: 27689616 [TBL] [Abstract][Full Text] [Related]
18. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma. Luan F; Liu P; Ma H; Yue X; Liu J; Gao L; Liang X; Ma C Int J Biochem Cell Biol; 2014 Oct; 55():129-35. PubMed ID: 25195714 [TBL] [Abstract][Full Text] [Related]
19. Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients. Jeon Y; Kim H; Jang ES; Hong S; Kim JW; Yoon YS; Cho JY; Han HS; Jeong SH APMIS; 2016 Mar; 124(3):208-15. PubMed ID: 26764243 [TBL] [Abstract][Full Text] [Related]
20. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues]. Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]